Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer
To access this article, please choose from the options below
PII: S0958-3947(10)00067-1
doi:10.1016/j.meddos.2010.05.001
© 2011 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
